Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism

Brigitte Sola 1 Marc Poirot 2, 3, 4 Philippe De Medina 2, 4 Sophie Bustany 1 Véronique Marsaud 5 Sandrine Silvente-Poirot 2, 3, 4 Jack-Michel Renoir 5, *
* Auteur correspondant
1 MILPAT - Microenvironnement cellulaire et pathologie
2 CRCT - Centre de Recherche en Cancérologie de Toulouse
3 Institut Claudius Regaud
4 UPS - Université Toulouse III - Paul Sabatier
5 U749 - Recepteurs et Signalisation des Interleukines
Abstract : Multiple myeloma (MM) is a malignancy characterized by the accumulation of clonal plasma cells in the bone marrow. Despite extensive efforts to design drugs targeting tumoral cells and their microenvironment, MM remains an incurable disease for which new therapeutic strategies are needed. We demonstrated here that antiestrogens (AEs) belonging to selective estrogen receptor modulators family induce a caspase-dependent apoptosis and trigger a protective autophagy. Autophagy was recognized by monodansylcadaverin staining, detection of autophagosomes by electronic microscopy, and detection of the cleaved form of the microtubule-associated protein light chain 3. Moreover, autophagy was inhibited by drugs such as bafilomycin A1 and 3-methyladenosine. Autophagy was mediated by the binding of AEs to a class of receptors called the antiestrogen binding site (AEBS) different from the classical estrogen nuclear receptors. The binding of specific ligands to the AEBS was accompanied by alteration of cholesterol metabolism and in particular accumulation of sterols: zymostenol or desmosterol depending on the ligand. This was due to the inhibition of the cholesterol-5,6-epoxide hydrolase activity borne by the AEBS. We further showed that the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin pathway mediated autophagy signaling. Moreover, AEBS ligands restored sensitivity to dexamethasone in resistant MM cells. Since we showed previously that AEs arrest MM tumor growth in xenografted mice, we propose that AEBS ligands may have a potent antimyeloma activity alone or in combination with drugs used in clinic.
keyword : cholesterol metabolism multiple myeloma tamoxifen autophagy apoptosis
Type de document :
Article dans une revue
Oncotarget, Impact journals, 2013, 4 (6), pp.911-922. 〈10.18632/oncotarget.1066〉
Liste complète des métadonnées

Littérature citée [43 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-00968940
Contributeur : Marc Poirot <>
Soumis le : mercredi 2 avril 2014 - 11:30:53
Dernière modification le : jeudi 13 septembre 2018 - 01:00:34
Document(s) archivé(s) le : mercredi 2 juillet 2014 - 10:51:19

Fichier

1066-9296-4-PB_1_.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

UNIV-TLSE3 | ICR | IGR | FNCLCC | COMUE-NORMANDIE

Citation

Brigitte Sola, Marc Poirot, Philippe De Medina, Sophie Bustany, Véronique Marsaud, et al.. Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism. Oncotarget, Impact journals, 2013, 4 (6), pp.911-922. 〈10.18632/oncotarget.1066〉. 〈inserm-00968940〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

682

Téléchargements de fichiers

179

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD